X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
index medicus (18) 18
female (15) 15
male (15) 15
care and treatment (12) 12
middle aged (12) 12
oncology (12) 12
aged (11) 11
cancer (11) 11
adult (10) 10
aged, 80 and over (7) 7
metastasis (7) 7
patients (7) 7
chemotherapy (6) 6
research (6) 6
medicine & public health (5) 5
tumors (5) 5
abridged index medicus (4) 4
antineoplastic agents (4) 4
cancer research (4) 4
disease progression (4) 4
drug dosages (4) 4
monosaccharides (4) 4
neoplasms - drug therapy (4) 4
olaparib (4) 4
pharmacology & pharmacy (4) 4
pharmacology/toxicology (4) 4
prognosis (4) 4
sugars (4) 4
treatment outcome (4) 4
analysis (3) 3
antimitotic agents (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
aufsatzsammlung (3) 3
cell lung-cancer (3) 3
cells (3) 3
clinical trials (3) 3
combination (3) 3
diarrhea (3) 3
dna repair (3) 3
double-blind method (3) 3
electronic books (3) 3
general (3) 3
hematology, oncology and palliative medicine (3) 3
history (3) 3
inhibitor (3) 3
internal medicine (3) 3
kaplan-meier estimate (3) 3
medical research (3) 3
melanoma (3) 3
metastases (3) 3
nausea (3) 3
open-label (3) 3
phthalazines - administration & dosage (3) 3
piperazines - administration & dosage (3) 3
poly polymerase inhibitors (3) 3
skin neoplasms - drug therapy (3) 3
skin neoplasms - pathology (3) 3
solid tumors (3) 3
surgery (3) 3
therapy (3) 3
united states (3) 3
young adult (3) 3
02 (2) 2
20th century (2) 2
adolescent (2) 2
advanced solid tumors (2) 2
african americans (2) 2
angiography (2) 2
animals (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
basal cell carcinoma (2) 2
benzimidazoles - administration & dosage (2) 2
biology (2) 2
biphenyl compounds - administration & dosage (2) 2
biphenyl compounds - adverse effects (2) 2
carboplatin (2) 2
carcinoma, basal cell - drug therapy (2) 2
cardiology (2) 2
cell cycle (2) 2
cisplatin (2) 2
clinical study (2) 2
coronary artery bypass (2) 2
coronary disease (2) 2
coronary heart disease (2) 2
ctla-4 antigen - immunology (2) 2
cytotoxicity (2) 2
dacarbazine - analogs & derivatives (2) 2
disease-free survival (2) 2
dna mutational analysis (2) 2
double-blind (2) 2
drug therapy (2) 2
endocrinology & metabolism (2) 2
fatigue (2) 2
flow cytometry (2) 2
foreign relations (2) 2
forskningsmetoder (2) 2
genetic aspects (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
UofT at Mississauga - Stacks (3) 3
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Faculty of Information - Stacks (1) 1
OISE - Reference (1) 1
Royal Ontario Museum - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
University College (Laidlaw) - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 75, Issue 1, pp. 113 - 125.e5
Background The hedgehog pathway inhibitor sonidegib demonstrated meaningful tumor shrinkage in more than 90% of patients with locally advanced basal cell... 
Dermatology | Basal Cell Carcinoma Outcomes with LDE225 Treatment study | hedgehog pathway inhibitor | sonidegib | locally advanced basal cell carcinoma | metastatic basal cell carcinoma | advanced basal cell carcinoma | Locally advanced basal cell carcinoma | Advanced basal cell carcinoma | Metastatic basal cell carcinoma | Sonidegib | Hedgehog pathway inhibitor | HEDGEHOG PATHWAY | MULTICENTER | VISMODEGIB | MANAGEMENT | EFFICACY | GUIDELINES | OPEN-LABEL | DERMATOLOGY | DOSE-ESCALATION | UPDATE | INHIBITOR | Skin Neoplasms - drug therapy | Humans | Middle Aged | Carcinoma, Basal Cell - secondary | Biphenyl Compounds - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Biphenyl Compounds - therapeutic use | Young Adult | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Smoothened Receptor - antagonists & inhibitors | Pyridines - therapeutic use | Skin Neoplasms - pathology | Pyridines - administration & dosage | Double-Blind Method | Survival Rate | Disease Progression | Biphenyl Compounds - administration & dosage | Carcinoma, Basal Cell - drug therapy | Aged | Medical research | Care and treatment | Basal cell carcinoma | Analysis | Patient outcomes | Corn | Medicine, Experimental | Skin | Metastasis | Drug therapy | Cancer
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2016, Volume 38, Issue 10, pp. 2286 - 2299
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 6, pp. 716 - 728
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 447 - 456
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 4, pp. 395 - 403
Abstract Background The extent of coronary disease affects clinical outcomes and may predict the effectiveness of coronary revascularization with either... 
Cardiovascular | Internal Medicine | coronary disease | prognosis | stents | angiography | ischemia | surgery | Transluminal angioplasty | Coronary artery bypass | Coronary heart disease | Medical imaging equipment
Journal Article
British Journal of Cancer, ISSN 0007-0920, 09/2017, Volume 117, Issue 7, pp. 938 - 946
Background: We investigated selumetinib (AZD6244, ARRY-142886), an oral, potent, and highly selective, allosteric MEK1/2 inhibitor, plus platinum-doublet... 
non-small cell lung cancer | selumetinib | chemotherapy | MEK1/2 inhibitor | PLUS GEMCITABINE | MULTICENTER | CARBOPLATIN | KRAS MUTATION | RANDOMIZED-TRIAL | OPEN-LABEL | DOCETAXEL | CELL LUNG-CANCER | CLINICAL-PRACTICE GUIDELINES | ONCOLOGY | AZD6244 ARRY-142886 | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Nausea - chemically induced | Chemotherapy-Induced Febrile Neutropenia - etiology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fatigue - chemically induced | Protein Kinase Inhibitors - adverse effects | Diarrhea - chemically induced | Cisplatin - administration & dosage | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Deoxycytidine - administration & dosage | Anemia - chemically induced | Carboplatin - administration & dosage | Epistaxis - chemically induced | Lethargy - chemically induced | Thrombocytopenia - chemically induced | Protein Kinase Inhibitors - administration & dosage | Vomiting - chemically induced | Pemetrexed - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Deoxycytidine - analogs & derivatives | Thrombocytopenia | Gemcitabine | Toxicity | Anemia | Lung cancer | Non-small cell lung carcinoma | Diarrhea | Fatigue | Nausea | Patients | Cisplatin | Metastases | Chemotherapy | Allosteric properties | Vomiting | Platinum | Lethargy | Carboplatin | Cancer | Neutropenia | MEK1 | 2 inhibitor | Clinical Study
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 10/2016, Volume 13, Issue 10, pp. 627 - 642
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 1, pp. 43 - 52
Journal Article
The Lancet Oncology, ISSN 1470-2045, 03/2019, Volume 20, Issue 3, pp. 383 - 393
Tisotumab vedotin is a first-in-human antibody–drug conjugate directed against tissue factor, which is expressed across multiple solid tumour types and is... 
ANTIBODY-DRUG CONJUGATE | TISSUE-FACTOR EXPRESSION | ONCOLOGY | IMMUNOTHERAPY | CARCINOMA | HI-CON1 | Care and treatment | Analysis | Metastasis
Journal Article
by Waubant, Emmanuelle and Amezcua, Lilyana and Sicotte, Nancy and Hellwig, Kerstin and Krupp, Lauren and Weinstock-Guttman, Bianca and Yeh, Ann and Lucas, Robyn M and Longbrake, Erin E and Yadav, Vijay and Rensel, Mary and Mar, Soe and Hersh, Carrie and Block, Valerie and Zipp, Frauke and Han, May H and Spain, Rebecca and Kelland, Eve E and Charvet, Leigh and Dimitri, Dalia and Papeix, Caroline and Cross, Anne H and Inglese, Matilde and Amato, Maria Pia and Airas, Laura and Leray, Emmanuelle and Sormani, Maria Pia and Van der Walt, Anneke and Vukusic, Sandra and Castillo-Trivino, Tamara and Tenembaum, Silvia and Ciccarelli, Olga and Bommarito, Giulia and Petracca, Maria and Celius, Elisabeth Gulowsen and Carson, Monica J and Hua, Le H and Van der Mei, Ingrid and Lubetzki, Catherine and Jokubaitis, Vilija and Trojano, Maria and Voskuhl, Rhonda and Tintore, Mar and Harbo, Hanne and Asgari, Nasrin and Piccio, Laura and Burton, Jodie M and Tremlett, Helen and Goldman, Myla D and Michel, Laure and Zhang, Yunyan and Bove, Riley and Quandt, Jacqueline A and Costello, Fiona and Ionete, Carolina and Lebrun-Frenay, Christine and Pakpoor, Julia and Bevan, Carolyn and Morrow, Sarah A and Waldman, Amy T and Oh, Jiwon and Jacobs, Dina and Palace, Jacqueline and Marrie, Ruth Ann and Tiwari-Woodruff, Seema K and Metz, Luanne M and Cortese, Rosa and Chitnis, Tanuja and Benson, Leslie and Benveniste, Etty (Tika) and Conway, Jill and Sand, Ilana Katz and Murphy, Jennifer Orthmann and Kita, Mariko and Riley, Claire and Goverman, Joan M and Langer-Gould, Annette M and Azevedo, Christina J and Morales, Idanis Berrios and Barcellos, Lisa F and Crabtree, Elizabeth and Plummer, Prue and Shirani, Afsaneh and Whartenby, Katherine and Brilot-Turville, Fabienne and Kingwell, Elaine and Coyle, Patricia and Mowry, Ellen and Zabad, Rana and Bielekova, Bibi and Monson, Nancy and Laule, Cornelia and Burnett, Margaret and Schreiner, Teri and Grinspan, Judith and Dobson, Ruth and Akassoglou, Katerina and Graves, Jennifer and Gray, Orla and Smyth, Penelope and ... and Int Women In MS and International Women in MS
Annals of Neurology, ISSN 0364-5134, 12/2018, Volume 84, Issue 6, pp. 958 - 959
Journal Article